使用Player FM应用程序离线!
Unravelling lentigo maligna
Manage episode 354674251 series 2943492
Lentigo maligna – a subtype of in situ melanoma – presents diagnostic and treatment challenges for clinicians.
In this podcast, Dr Michael Rtshiladze leads a multidisciplinary discussion to unravel our understanding of the pathology, diagnosis and management of lentigo maligna, including:
- clinical and histological presentation
- tools to diagnose and monitor lesions
- the impact of different types of biopsies
- the importance of mapping the extent of lesions
- the challenge of surgical management in cosmetically sensitive areas
- the role of radiation therapy and topical treatments
- when to refer your patient.
The discussion concludes with a case study to summarise key learnings.
This podcast is suitable for Plastic Surgeons, General Surgeons, Dermatologists, Oncologists, Pathologists, GPs, Nurses and other healthcare professionals.
SPEAKERS
- Dr Michael Rtshiladze - Plastic and Reconstructive Surgeon, Melanoma Institute Australia, Royal Prince Alfred Hospital, The Prince of Wales Hospital, St George Hospital and Sydney Children’s Hospital
- Dr Robert Rawson - Pathologist, Melanoma Institute Australia and Royal Prince Alfred Hospital
- Prof Pascale Guitera - Dermatologist, Melanoma Institute Australia | Director, Sydney Melanoma Diagnostic Centre at Royal Prince Alfred Hospital | Professorial Research Fellow, The University of Sydney
- Prof Angela Hong - Radiation Oncologist, Melanoma Institute Australia | Clinical Professor, The University of Sydney
RESOURCE AND REFERENCE
- Lentigo Maligna Patient Information Brochure
- Crouch G, Sinha S, Lo S, Saw RPM, Lee KK, Stretch J, Shannon K, Guitera P, Scolyer RA, Thompson JF & Ch'ng S. Clinical outcomes following surgical treatment of lentigo maligna of the head and neck. Eur J Surg Oncol. 2021 May;47(5):1145-1151.
Please note that this podcast was accurate at the time of recording (December 2022) but may not reflect the rapidly evolving treatment landscape and approvals in Australia.
MIA’s Education Program is proudly supported through unrestricted educational grants from MSD, Bristol Myers Squibb and HEINE.
22集单集
Manage episode 354674251 series 2943492
Lentigo maligna – a subtype of in situ melanoma – presents diagnostic and treatment challenges for clinicians.
In this podcast, Dr Michael Rtshiladze leads a multidisciplinary discussion to unravel our understanding of the pathology, diagnosis and management of lentigo maligna, including:
- clinical and histological presentation
- tools to diagnose and monitor lesions
- the impact of different types of biopsies
- the importance of mapping the extent of lesions
- the challenge of surgical management in cosmetically sensitive areas
- the role of radiation therapy and topical treatments
- when to refer your patient.
The discussion concludes with a case study to summarise key learnings.
This podcast is suitable for Plastic Surgeons, General Surgeons, Dermatologists, Oncologists, Pathologists, GPs, Nurses and other healthcare professionals.
SPEAKERS
- Dr Michael Rtshiladze - Plastic and Reconstructive Surgeon, Melanoma Institute Australia, Royal Prince Alfred Hospital, The Prince of Wales Hospital, St George Hospital and Sydney Children’s Hospital
- Dr Robert Rawson - Pathologist, Melanoma Institute Australia and Royal Prince Alfred Hospital
- Prof Pascale Guitera - Dermatologist, Melanoma Institute Australia | Director, Sydney Melanoma Diagnostic Centre at Royal Prince Alfred Hospital | Professorial Research Fellow, The University of Sydney
- Prof Angela Hong - Radiation Oncologist, Melanoma Institute Australia | Clinical Professor, The University of Sydney
RESOURCE AND REFERENCE
- Lentigo Maligna Patient Information Brochure
- Crouch G, Sinha S, Lo S, Saw RPM, Lee KK, Stretch J, Shannon K, Guitera P, Scolyer RA, Thompson JF & Ch'ng S. Clinical outcomes following surgical treatment of lentigo maligna of the head and neck. Eur J Surg Oncol. 2021 May;47(5):1145-1151.
Please note that this podcast was accurate at the time of recording (December 2022) but may not reflect the rapidly evolving treatment landscape and approvals in Australia.
MIA’s Education Program is proudly supported through unrestricted educational grants from MSD, Bristol Myers Squibb and HEINE.
22集单集
모든 에피소드
×欢迎使用Player FM
Player FM正在网上搜索高质量的播客,以便您现在享受。它是最好的播客应用程序,适用于安卓、iPhone和网络。注册以跨设备同步订阅。